Christo Grozev

Lead Russia investigator with Bellingcat

Christo Grozev on KCRW

Director Daniel Roher and journalist Christo Grozev discuss the many risks they faced in making the bio-doc on Russian opposition leader “Navalny.”

Encore: Navalny’ director Daniel Roher on making ‘our own little spy film’

Director Daniel Roher and journalist Christo Grozev discuss the many risks they faced in making the bio-doc on Russian opposition leader “Navalny.”

from The Business

Director Daniel Roher and journalist Christo Grozev discuss meeting with Russian opposition leader, and the risks they faced to make the bio-doc “Navalny.”

'Navalny' was like making 'our own little spy film,' filmmaker says

Director Daniel Roher and journalist Christo Grozev discuss meeting with Russian opposition leader, and the risks they faced to make the bio-doc “Navalny.”

from The Business

More from KCRW

Netflix had a strong fourth quarter, adding 19 million subscribers to the streaming service before raising subscription prices across the board.

from The Business

This East LA artist isn’t just painting lowriders, she’s carving out space for women in the male-dominated lowrider scene, turning car culture into fine art.

from KCRW Features

Elvis chats with Oscar-nominated Aunjanue Ellis-Taylor, director Walter Salles, and director Pablo Larraín for The Treat.

from The Treatment

Nature, the great outdoors, and our interdependence.

from Life Examined

The latest film releases include Love Hurts, Heart Eyes, Parthenope, and Armand.

from Weekend Film Reviews

Dig deep into the Bob Dylan biopic “A Complete Unknown” with Best Supporting Actor nominee Edward Norton, director James Mangold, and costumer Arianne Phillips.

from The Treatment

The latest film releases include Kraven the Hunter, The Lord of the Rings: The War of the Rohirrim, The End, and September 5.

from Weekend Film Reviews

Adam Scott talks “Severance” season 2, Pablo Larrain tells us about loving opera and telling the story of Maria Callas, and Tiffany Haddish has The Treat.

from The Treatment

As 2024 comes to an end, we want to thank you, our listeners! We asked you to send us your burning questions about the industry, and you delivered – from around the world.

from The Business